Search Articles — Sudonull

Search Results

In this project

AI in the labor market: risks and data 2026

https://sudonull.com/ai-in-the-labor-market-risks-and-data-2026

Analysis of professions' susceptibility to AI based on O*NET and Anthropic. Slowdown in hiring young specialists. Study the methodology and conclusions for assessing risks in IT. More details in the article.

Foldable iPhone and robot: 10 new Apple products after CEO change

https://sudonull.com/foldable-iphone-and-robot-10-new-apple-products-after-ceo-change

Apple is preparing more than 10 devices: a foldable iPhone for $2000, a home robot, and smart glasses. Learn about Apple's strategy and how the ecosystem will change. Read more in the article!

Theft of $292M from Kelp DAO: Details of the Bridge Attack

https://sudonull.com/theft-of-292m-from-kelp-dao-details-of-the-bridge-attack

Hacker withdrew 116,500 rsETH from the Kelp DAO protocol. Vulnerability in the cross-chain bridge, team response, and market implications. Read in the analytical article.

AI for scientific articles: process in 2 hours

https://sudonull.com/ai-for-scientific-articles-process-in-2-hours

Learn how to use AI to automate scientific articles: from dictation to 94% original text. Step-by-step case for researchers. Master the method and reduce routine.

From other projects

VER-01 breakthrough therapy FDA: non-opioid analgesic

https://ymaho.com/ver-01-breakthrough-therapy-fda-non-opioid-analgesic

FDA granted breakthrough therapy status to non-opioid analgesic VER-01. The drug is more effective than opioids and safer for the gastrointestinal tract. Details in the article.

CRISPR vision restoration: FDA approval for testing

https://ymaho.com/crispr-vision-restoration-fda-approval-for-testing

A US startup received FDA approval to test CRISPR therapy for people born blind with Leber congenital amaurosis. Details, risks, and prospects in the article.

Trans-retinol in anti-aging care: why it is indispensable

https://ymaho.com/trans-retinol-in-anti-aging-care-why-it-is-indispensable

Analysis of Byrdie's article on trans-retinol: biochemistry, regulatory risks in the EU, and why 'slow retinol' is marketing. Learn how to safely use the main anti-aging component.

AlphaFold DB: How AI Predicted 200 Million Proteins

https://ymaho.com/alphafold-db-how-ai-predicted-200-million-proteins

DeepMind's AlphaFold database contains over 200 million protein structures. Learn how this accelerates drug discovery and transforms science. Read more in the article.

Malaria vaccine R21 approved by WHO: 75% efficacy

https://ymaho.com/malaria-vaccine-r21-approved-by-who-75-efficacy

WHO approved second malaria vaccine R21/Matrix-M with 75% efficacy. Learn about benefits, price, and impact on children's health in Africa. Read more in the article.

PDRN in hair care: the salmon-DNA trend in cosmetology

https://ymaho.com/pdrn-in-hair-care-the-salmon-dna-trend-in-cosmetology

Learn how PDRN from cosmetology is moving into shampoos and serums for hair. Analysis of the trend, risks, and forecasts from trichologists. Read the article!

Biotechnologies in Cosmetics: The Future of Skincare

https://ymaho.com/biotechnologies-in-cosmetics-the-future-of-skincare

Learn how biotechnologies are replacing plant extracts in cosmetics. Advantages of fermentation, market forecasts, and impact on the industry. Read the article!

From the web

Chalice Cannabis

https://www.chalicecannabis.com/

Chalice operates a network of cannabis dispensaries across Oregon, including locations in Portland, Bend, Salem, Eugene, Tigard, Dundee, Albany, and Oregon City.

5 days ago ·

https://www.marketwatch.com/investing/stock/chalf

5 days ago · Chalice Brands Ltd. is engaged in the development, processing, and distribution of medical cannabis products. The firm offers products under the Golden XTRX, Proper, and Left Coast Connection...

4 days ago ·

https://www.wsj.com/market-data/stock/chalf

4 days ago · View the latest Chalice Brands Ltd. (CHALF) stock price, news, historical charts, analyst ratings and financial information from The Wall Street Journal.

Trending Now